Sagility Ltd

Sagility gains after arm signs pact to acquire US-based CareSeed

12 Jun 2026

Sagility added 1.73% to Rs 39.32 after its step-down subsidiary, Sagility LLC has signed a definitive agreement to acquire US-based CareSeed, a healthcare analytics firm.

The acquisition, approved by the board of directors at its meeting held on June 11, 2026, is a cash transaction. The deal is expected to be completed on the same date. CareSeed, headquartered in Kansas City, Missouri, reported a turnover of USD 5.1 million in CY2025. The company operates in the US healthcare analytics and technology space, offering NCQA-certified HEDIS reporting, medical record review, chart abstraction, and regulatory analytics solutions for health plans. Sagility said the acquisition aligns with its strategy to strengthen healthcare quality measurement and risk adjustment capabilities and expand into STAR performance management and care gap closure services. CareSeed currently serves around 30 mid-sized US health plans, primarily in the Medicare Advantage segment. Its cloud-based platforms, Forecast and Harvest, support HEDIS reporting, audit readiness, and regulatory compliance. The company said the acquisition will enhance its healthcare quality and Stars capabilities and enable expansion into integrated quality orchestration across payer ecosystems. The deal is expected to strengthen Sagility's position in the US healthcare payer market and create cross-selling opportunities across technology and clinical services. Sagility is a global provider of technology-enabled business solutions and services to clients in the U.S. healthcare industry. The company's consolidated net profit jumped 41.2% to Rs 257.73 crore on 29.1% rise in revenue from operations to Rs 2,024.26 crore in Q4 FY26 over Q4 FY25. Powered by Capital Market - Live News

Sagility Q3 PAT rises 23% YoY to Rs 268 cr

29 Jan 2026

Sagility reported a 23.4% increase in consolidated net profit to Rs 267.66 crore on a 35.7% rise in revenue from operations to Rs 1,971.15 crore in Q3 FY26 over Q3 FY25.

The company reported profit before exceptional items and tax of Rs 371.34 crore in Q3 FY26, compared with Rs 289.81 crore a year ago. The quarter included exceptional items of Rs 32.82 crore due to a one-time impact from India's new labor codes, effective 21 November 2025, related to long-term employee benefits. In Q3 FY26, adjusted EBITDA stood at Rs 512.5 crore, up 24.2%, compared with Rs 412.7 crore posted in the same quarter last year. Adjusted EBITDA margin stood at 26% in Q3 FY26 as against 28.4% in Q3 FY25. In dollar terms, the company reported revenue of $222 million, while adjusted PAT stood at $36.4 million in Q3 FY26. In constant currency terms, revenue grew 29.1% YoY, while organic growth came in at 19.9% YoY (13.9% in constant currency). As of 31st December 2025, the company had 48,522 employees and operated 35 delivery centers across five countries. Attrition improved to 22.8% in Q3 FY26 as against 21.8% in Q3 FY25. Ramesh Gopalan, managing director and group CEO, said, 'Building on the momentum from the first half of the year, our performance in this quarter has been exceptional. The open enrollment period was particularly successful, with strong outcomes across our large payer relationships. The addition of BroadPath expanded our exposure to open-enrollment-driven work and a broader payer client base. This was supported by disciplined and reliable execution. As clients navigate an evolving regulatory and profitability environment, engagements are increasingly shaped by outcome-oriented delivery models with a strong focus on cost reduction. This shift is clearly reflected in our deal pipeline with more complex constructs anchored in outcomes and efficiency commitments on the back of technology and transformation. Our execution excellence and our continued commitment to helping our clients navigate the immediate challenges place us in a strong position. We remain confident in sustaining this momentum through the final quarter.' Abhishek Kayan, deputy chief financial officer, added, 'This quarter's performance reflects our ability to scale rapidly while maintaining financial discipline. We delivered strong revenue growth without compromising margins, driven by operational excellence, robust cost management, and focused execution across the business. This has enabled us to maintain a healthy balance sheet, progressively reduce debt, and preserve financial flexibility. We will continue to allocate capital selectively, prioritizing investments in AI, domain capabilities, and the development of an AI-ready, healthcare-focused workforce, while maintaining a prudent approach to costs. This balance between financial discipline and strategic investment positions us well to sustain growth and margins and strengthen the long-term economics of the business.' Sagility is a global provider of technology-enabled business solutions and services to clients in the U.S. healthcare industry. Shares of Sagility fell 3.13% to Rs 50.07 on the BSE. Powered by Capital Market - Live News

Sagility schedules AGM

11 Jul 2026

On 20 August 2026

Sagility announced that the 5th Annual General Meeting(AGM) of the company will be held on 20 August 2026.

Board of Sagility recommends final dividend

13 May 2026

Of Rs 0.1 per share

Sagility announced that the Board of Directors of the Company at its meeting held on 12 May 2026, inter alia, have recommended the final dividend of Rs 0.1 per equity Share (i.e. 1%) , subject to the approval of the shareholders.

Sagility to table results

7 May 2026

On 12 May 2026

Sagility will hold a meeting of the Board of Directors of the Company on 12 May 2026.

Sagility consolidated net profit rises 41.17% in the March 2026 quarter

13 May 2026

Sales rise 29.06% to Rs 2024.26 crore

Net profit of Sagility rose 41.17% to Rs 257.73 crore in the quarter ended March 2026 as against Rs 182.57 crore during the previous quarter ended March 2025. Sales rose 29.06% to Rs 2024.26 crore in the quarter ended March 2026 as against Rs 1568.48 crore during the previous quarter ended March 2025. For the full year,net profit rose 71.53% to Rs 924.77 crore in the year ended March 2026 as against Rs 539.12 crore during the previous year ended March 2025. Sales rose 29.14% to Rs 7192.85 crore in the year ended March 2026 as against Rs 5569.92 crore during the previous year ended March 2025. Particulars Quarter Ended Year Ended Mar. 2026 Mar. 2025 % Var. Mar. 2026 Mar. 2025 % Var. Sales 2024.26 1568.48 29 7192.85 5569.92 29 OPM % 23.94 23.78 - 24.47 23.30 - PBDT 487.34 353.32 38 1759.09 1227.09 43 PBT 363.18 238.99 52 1271.72 760.23 67 NP 257.73 182.57 41 924.77 539.12 72 Powered by Capital Market - Live News

Sagility consolidated net profit rises 23.40% in the December 2025 quarter

29 Jan 2026

Sales rise 35.65% to Rs 1971.15 crore

Net profit of Sagility rose 23.40% to Rs 267.66 crore in the quarter ended December 2025 as against Rs 216.91 crore during the previous quarter ended December 2024. Sales rose 35.65% to Rs 1971.15 crore in the quarter ended December 2025 as against Rs 1453.07 crore during the previous quarter ended December 2024. Particulars Quarter Ended Dec. 2025 Dec. 2024 % Var. Sales 1971.15 1453.07 36 OPM % 25.93 26.99 - PBDT 494.86 405.99 22 PBT 371.34 289.81 28 NP 267.66 216.91 23 Powered by Capital Market - Live News